Lipoprotein(a) levels and risk of abdominal aortic aneurysm in the Women's Health Initiative.


Journal

Journal of vascular surgery
ISSN: 1097-6809
Titre abrégé: J Vasc Surg
Pays: United States
ID NLM: 8407742

Informations de publication

Date de publication:
04 2021
Historique:
received: 13 05 2020
accepted: 26 07 2020
pubmed: 4 9 2020
medline: 12 10 2021
entrez: 4 9 2020
Statut: ppublish

Résumé

Few studies have prospectively examined the associations of lipoprotein(a) [Lp(a)] levels with the risk of abdominal aortic aneurysm (AAA), especially in women. Accounting for commonly recognized risk factors, we investigated the baseline Lp(a) levels and the risk of AAA among postmenopausal women participating in the ongoing national Women's Health Initiative. Women's Health Initiative participants with baseline Lp(a) levels available who were beneficiaries of Medicare parts A and B fee-for-service at study enrollment or who had aged into Medicare at any point were included. Participants with missing covariate data or known AAA at baseline were excluded. Thoracic aneurysms were excluded owing to the different pathophysiology. The AAA cases and interventions were identified using the International Classification of Diseases, 9th and 10th revision, codes and Current Procedural Terminology codes from claims data. Hazard ratios were computed using Cox proportional hazard models according to the quintiles of Lp(a). The mean age of the 6615 participants included in the analysis was 65.3 years. Of the 6615 participants, 66.6% were non-Hispanic white, 18.9% were black, 7% were Hispanic and 4.7% were Asian/Pacific Islander. Compared with the participants in the lowest Lp(a) quintile, those in higher quintiles were more likely to be overweight, black, and former or current smokers, to have hypertension, hyperlipidemia, and a history of cardiovascular disease, and to use menopausal hormone therapy and statins. During 65,476 person-years of follow-up, with a median of 10.4 years, 415 women had been diagnosed with an AAA and 36 had required intervention. More than one half had required intervention for a ruptured AAA. We failed to find a statistically significant association between Lp(a) levels and incident AAA. Additional sensitivity analyses stratified by race, with exclusion of statin users and alternative categorizations of Lp(a) using log-transformed levels, tertiles, and a cutoff of >50 mg/dL, were conducted, which did not reveal any significant associations. We found no statistically significant association between Lp(a) levels and the risk of AAA in a large and well-phenotyped sample of postmenopausal women. Women with high Lp(a) levels were more likely to be overweight, black, and former or current smokers, and to have hypertension, hyperlipidemia, and a history of cardiovascular disease, or to use hormone therapy and statins compared with those with lower Lp(a) levels. These findings differ from previous prospective, case-control, and meta-analysis studies that had supported a significant relationship between higher Lp(a) levels and an increased risk of AAA. Differences in the association could have resulted from study limitations or sex differences.

Identifiants

pubmed: 32882349
pii: S0741-5214(20)31908-X
doi: 10.1016/j.jvs.2020.07.106
pmc: PMC7914280
mid: NIHMS1626691
pii:
doi:

Substances chimiques

Biomarkers 0
LPA protein, human 0
Lipoprotein(a) 0

Types de publication

Journal Article Multicenter Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1245-1252.e3

Subventions

Organisme : NHLBI NIH HHS
ID : HHSN268201600002C
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201600018C
Pays : United States
Organisme : NHLBI NIH HHS
ID : T32 HL007208
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201600003C
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201600004C
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201600001C
Pays : United States

Informations de copyright

Copyright © 2020 Society for Vascular Surgery. All rights reserved.

Références

Atherosclerosis. 2018 Jan;268:63-67
pubmed: 29182987
J Am Coll Cardiol. 2014 Feb 11;63(5):470-7
pubmed: 24161338
Interact Cardiovasc Thorac Surg. 2009 Sep;9(3):467-70
pubmed: 19564206
Control Clin Trials. 1998 Feb;19(1):61-109
pubmed: 9492970
Ann Intern Med. 2015 Jul 7;163(1):40-51
pubmed: 25915661
Lancet. 2002 Nov 16;360(9345):1531-9
pubmed: 12443589
J Clin Epidemiol. 1993 Jul;46(7):617-24
pubmed: 8326346
J Vasc Surg. 2016 Mar;63(3):839-44
pubmed: 26747679
Arterioscler Thromb Vasc Biol. 2015 Apr;35(4):996-1001
pubmed: 25810300
JAMA. 2019 Dec 10;322(22):2211-2218
pubmed: 31821437
Atherosclerosis. 2018 Dec;279:107-113
pubmed: 30290962
J Lipid Res. 1987 Jan;28(1):69-79
pubmed: 2951469
Br J Surg. 2016 Aug;103(9):1097-104
pubmed: 27346306
J Vasc Surg. 2006 Feb;43(2):230-8; discussion 238
pubmed: 16476592
Arch Intern Med. 1994 May 23;154(10):1106-10
pubmed: 8185424
J Am Coll Cardiol. 2017 Feb 14;69(6):692-711
pubmed: 28183512
J Vasc Surg. 2002 Jul;36(1):25-30
pubmed: 12096252
Ann Epidemiol. 2003 Oct;13(9 Suppl):S107-21
pubmed: 14575943
Clin Chem. 2014 Jan;60(1):174-85
pubmed: 24048437
J Vasc Surg. 2014 Jul;60(1):98-105
pubmed: 24636641
Horm Metab Res. 2006 Sep;38(9):581-6
pubmed: 16981140
JAMA. 2002 Aug 28;288(8):980-7
pubmed: 12190368
JAMA. 2003 May 28;289(20):2673-84
pubmed: 12771114
J Vasc Surg. 2010 Sep;52(3):539-48
pubmed: 20630687
J Lipid Res. 1989 Sep;30(9):1437-43
pubmed: 2532239
Clin Chem. 1972 Jun;18(6):499-502
pubmed: 4337382
Angiology. 2017 Feb;68(2):99-108
pubmed: 26980774
Circulation. 2019 Mar 19;139(12):1483-1492
pubmed: 30586750
Clin Chem. 2001 Sep;47(9):1673-8
pubmed: 11514402
JAMA. 2019 Nov 18;:
pubmed: 31738818
Eur J Clin Invest. 1996 Feb;26(2):109-14
pubmed: 8904519
Circulation. 2012 Apr 10;125(14):1748-56, S1-11
pubmed: 22399535
J Am Heart Assoc. 2019 Jun 18;8(12):e012406
pubmed: 31165670
Stroke. 2007 Jun;38(6):1959-66
pubmed: 17478739
J Clin Lipidol. 2019 May - Jun;13(3):374-392
pubmed: 31147269
Circulation. 2000 Sep 5;102(10):1082-5
pubmed: 10973834
BMJ Open. 2019 Apr 24;9(4):e027257
pubmed: 31023762
JAMA. 2009 Jun 10;301(22):2331-9
pubmed: 19509380
Arterioscler Thromb Vasc Biol. 1997 Sep;17(9):1822-9
pubmed: 9327783
Ann Epidemiol. 2003 Oct;13(9 Suppl):S5-17
pubmed: 14575938
Sci Rep. 2018 May 16;8(1):7726
pubmed: 29769559
J Am Coll Cardiol. 2019 Sep 24;74(12):1543-1553
pubmed: 31537263
Clin Chem. 2007 Apr;53(4):679-85
pubmed: 17303687
Arterioscler Thromb Vasc Biol. 1996 Oct;16(10):1215-21
pubmed: 8857916
J Am Coll Cardiol. 2008 Jul 8;52(2):124-31
pubmed: 18598891
N Engl J Med. 2009 Dec 24;361(26):2518-28
pubmed: 20032323
Stroke. 2012 Apr;43(4):958-66
pubmed: 22308251
Maturitas. 2017 May;99:27-36
pubmed: 28364865
Br J Surg. 2013 Feb;100(3):367-72
pubmed: 23192439
J Lipid Res. 2016 Nov;57(11):1953-1975
pubmed: 27677946

Auteurs

Elizabeth L Chou (EL)

Division of Vascular and Endovascular Surgery, Massachusetts General Hospital, Boston, Mass. Electronic address: elchou@mgh.harvard.edu.

Mary Pettinger (M)

Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Wash.

Bernhard Haring (B)

Department of Internal Medicine, University of Würzburg, Würzburg, Germany.

Matthew W Mell (MW)

Division of Vascular Surgery, University of California, Davis, Medical Center, Sacramento, Calif.

Mark A Hlatky (MA)

Department of Health Research and Policy, Stanford University School of Medicine, Stanford, Calif.

Jean Wactawski-Wende (J)

Department of Epidemiology and Environmental Health, State University of New York at Buffalo, Buffalo, NY.

Matthew A Allison (MA)

Department of Family Medicine and Public Health, University of California, San Diego, School of Medicine, La Jolla, Calif.

Robert A Wild (RA)

Department of Obstetrics and Gynecology, University of Oklahoma Health Sciences Center, Oklahoma City, Okla.

Aladdin H Shadyab (AH)

Department of Family Medicine and Public Health, University of California, San Diego, School of Medicine, La Jolla, Calif.

Robert B Wallace (RB)

Department of Epidemiology, College of Public Health, The University of Iowa, Iowa City, Iowa.

Linda G Snetselaar (LG)

Department of Epidemiology, College of Public Health, The University of Iowa, Iowa City, Iowa.

Matthew J Eagleton (MJ)

Division of Vascular and Endovascular Surgery, Massachusetts General Hospital, Boston, Mass.

Mark F Conrad (MF)

Division of Vascular and Endovascular Surgery, Massachusetts General Hospital, Boston, Mass.

Simin Liu (S)

Department of Epidemiology and Medicine, Brown University, Providence, RI.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH